Compliance with Market Abuse Regulation

RNS Number : 4265M
Aberdeen New Dawn Invest Trust PLC
23 May 2022
 

 

Aberdeen New Dawn Investment Trust plc

Legal Entity Identifier:  5493002K00AHWEME3J36

 

 

23 May 2022

 

 

Aberdeen New Dawn Investment Trust plc (the "Company") announces that it is satisfied that any inside information which the Directors or the Company may have had up to today's date has previously been notified to a Regulated Information Service ("RIS").

 

By virtue of the points set out in (1) to (5) below, the Directors and the Company do not currently expect there to be any inside information arising in the closed period which will end on the date of the announcement of the Company's Annual Financial Report for the year ended 30 April 2022.

 

1)  the announcement on 6 May 2022 of the Company's net asset value per share as of the close of business on 30 April 2022,

2)  the Company's belief, following reasonable enquiries, that there will be no material difference between the information published on 6 May 2022 and that to be included in the forthcoming announcement of the Annual Financial Report,

3)  the Company's practice of calculating net asset values per share each business day and the announcement of these net asset values to an RIS,

4)  there being no unquoted investments within the Company's portfolio, and

5)  there being no other unpublished information which constitutes price-sensitive information in respect of the Company's securities.

 

The Company is therefore not prohibited from dealing in its own securities during the closed period.

 

If, during the closed period leading up to the announcement of the Annual Financial Report, the Company or its Directors become aware of any inside information, such inside information will be managed in accordance with the UKLA's DTR 2.

 

 

F or further information, please contact:

Gordon Hay Smith

Aberdeen Asset Management PLC

Secretaries

 

Tel. 0131 372 2200

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CMCEAPSDALDAEEA
UK 100